CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Moderna

Market Opportunities - 23/02/2021

23 February, 2021

The example below uses Contracts For Difference (CFDs). Calculations are only on the price of the specific instrument on the date below and calculations indicate a possible opportunity for profit or loss. No representation or warranty is given as to the accuracy or completeness of this information, consequently any person acting on it does so entirely at their own risk.

Moderna weekly uptrend opportunity based On 1.00 Lot Calculation:

  • Moderna, Inc. a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.
  • EVENT: (Earning report Thursday, February 25, before market); Moderna is expected to report a loss per share of $0.36, which is a smaller loss by 33% compared to the prior-year quarter. Revenue is estimated to be around $280 million, or more than 20 times higher than the prior-year quarter. The company’s earnings beat estimates in three of the last four quarters and missed the same once.
  • Moderna said that following positive feedback from the U.S. Food and Drug Administration, it is pursuing a plan to increase the number of COVID-19 vaccine doses to up to 15 in each vial from the present 10 doses. The plan was disclosed as part of the biotechnology company’s written testimony ahead of a House hearing scheduled for Tuesday.
  • Moderna announced that the European Commission purchased an additional 150 million doses of its COVID-19 vaccine, to be delivered in the third and fourth quarter of 2021. This brings Europe’s total order to 310 million doses of for delivery in 2021. Moderna is on track to make 600 million doses of its coronavirus vaccine this year, Moderna CEO Stephane Bancel said. The company is now adding staff with the hopes of reaching 1 billion doses this year and up to 1.2 billion doses in 2022. This is key because Covid-19 is here to stay, Bancel predicted. Moderna shares closed 8.8% lower at $159.37 on Monday.

Moderna, February 23, 2021
Current Price: 143

Moderna

Weekly

Trend direction

UP

Resistance 3

184

Resistance 2

172

Resistance 1

158

Support 1

129

Support 2

116

Support 3

103

Example of calculation base on weekly trend direction for 1.00 Lot*

Moderna

Pivot Points

Resistance 3

Resistance 2

Resistance 1

Support 1

Support 2

Support 3

Profit or loss in $

41,000

29,000

15,000

-14,000

-27,000

-40,000

Profit or loss in €**

33,997

24,046

12,438

-11,609

-22,388

-33,167

Profit or loss in £**

29,454

20,833

10,776

-10,057

-19,397

-28,736

Profit or loss in C$**

52,029

36,801

19,035

-17,766

-34,263

-50,760

* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 14:30 am GMT 23/02/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more details

Share It With Your Network
Moderna Inc Chart
Update Time: -
Highest
Lowest
1M 5M H D W
Prices are loading..
Ready for trading?Start Now